Latest news with #RossStores
Yahoo
a day ago
- Business
- Yahoo
What To Expect From Five Below's (FIVE) Q1 Earnings
Discount retailer Five Below (NASDAQ:FIVE) will be reporting results tomorrow after market hours. Here's what to look for. Five Below beat analysts' revenue expectations by 1% last quarter, reporting revenues of $1.39 billion, up 4% year on year. It was a mixed quarter for the company, with EPS guidance for next quarter exceeding analysts' expectations but full-year EPS guidance missing analysts' expectations significantly. Is Five Below a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Five Below's revenue to grow 18.1% year on year to $958.5 million, improving from the 11.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.83 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Five Below has missed Wall Street's revenue estimates four times over the last two years. Looking at Five Below's peers in the discount retailer segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Ross Stores delivered year-on-year revenue growth of 2.6%, beating analysts' expectations by 0.5%, and TJX reported revenues up 5.1%, topping estimates by 0.7%. Ross Stores traded down 9.8% following the results while TJX was also down 4%. Read our full analysis of Ross Stores's results here and TJX's results here. There has been positive sentiment among investors in the discount retailer segment, with share prices up 10.1% on average over the last month. Five Below is up 43.3% during the same time and is heading into earnings with an average analyst price target of $108.47 (compared to the current share price of $118.65). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Sign in to access your portfolio
Yahoo
a day ago
- Business
- Yahoo
What To Expect From Five Below's (FIVE) Q1 Earnings
Discount retailer Five Below (NASDAQ:FIVE) will be reporting results tomorrow after market hours. Here's what to look for. Five Below beat analysts' revenue expectations by 1% last quarter, reporting revenues of $1.39 billion, up 4% year on year. It was a mixed quarter for the company, with EPS guidance for next quarter exceeding analysts' expectations but full-year EPS guidance missing analysts' expectations significantly. Is Five Below a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Five Below's revenue to grow 18.1% year on year to $958.5 million, improving from the 11.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.83 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Five Below has missed Wall Street's revenue estimates four times over the last two years. Looking at Five Below's peers in the discount retailer segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Ross Stores delivered year-on-year revenue growth of 2.6%, beating analysts' expectations by 0.5%, and TJX reported revenues up 5.1%, topping estimates by 0.7%. Ross Stores traded down 9.8% following the results while TJX was also down 4%. Read our full analysis of Ross Stores's results here and TJX's results here. There has been positive sentiment among investors in the discount retailer segment, with share prices up 10.1% on average over the last month. Five Below is up 43.3% during the same time and is heading into earnings with an average analyst price target of $108.47 (compared to the current share price of $118.65). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Yahoo
2 days ago
- Business
- Yahoo
Ollie's (OLLI) Reports Q1: Everything You Need To Know Ahead Of Earnings
Discount retail company Ollie's Bargain Outlet (NASDAQ:OLLI) will be announcing earnings results tomorrow before the bell. Here's what you need to know. Ollie's missed analysts' revenue expectations by 1.2% last quarter, reporting revenues of $667.1 million, up 2.8% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' gross margin estimates but full-year EPS guidance missing analysts' expectations. Is Ollie's a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Ollie's revenue to grow 11.3% year on year to $566.2 million, in line with the 10.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.71 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Ollie's has missed Wall Street's revenue estimates four times over the last two years. Looking at Ollie's peers in the discount retailer segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Ross Stores delivered year-on-year revenue growth of 2.6%, beating analysts' expectations by 0.5%, and TJX reported revenues up 5.1%, topping estimates by 0.7%. Ross Stores traded down 9.8% following the results while TJX was also down 4%. Read our full analysis of Ross Stores's results here and TJX's results here. There has been positive sentiment among investors in the discount retailer segment, with share prices up 9.8% on average over the last month. Ollie's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $125.88 (compared to the current share price of $110). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Business
- Yahoo
2 Large-Cap Stocks to Target This Week and 1 to Keep Off Your Radar
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task. This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here are two large-cap stocks with attractive long-term potential and one whose existing offerings may be tapped out. Market Cap: $63.97 billion Founded by scientists who wanted to build a company where science could thrive, Regeneron Pharmaceuticals (NASDAQ:REGN) develops and commercializes medicines for serious diseases, with key products treating eye conditions, allergic diseases, cancer, and other disorders. Why Does REGN Worry Us? Sizable revenue base leads to growth challenges as its 6.7% annual revenue increases over the last two years fell short of other healthcare companies Efficiency has decreased over the last five years as its adjusted operating margin fell by 12.3 percentage points Shrinking returns on capital suggest that increasing competition is eating into the company's profitability Regeneron's stock price of $605.39 implies a valuation ratio of 15.1x forward P/E. If you're considering REGN for your portfolio, see our FREE research report to learn more. Market Cap: $45.68 billion Selling excess inventory or overstocked items from other retailers, Ross Stores (NASDAQ:ROST) is an off-price concept that sells apparel and other goods at prices much lower than department stores. Why Are We Positive On ROST? Aggressive strategy of rolling out new stores to gobble up whitespace is prudent given its same-store sales growth Locations open for at least a year are seeing increased demand as same-store sales have averaged 3.5% growth over the past two years Stellar returns on capital showcase management's ability to surface highly profitable business ventures, and its returns are growing as it capitalizes on even better market opportunities At $138.93 per share, Ross Stores trades at 21.1x forward P/E. Is now a good time to buy? See for yourself in our full research report, it's free. Market Cap: $74.41 billion Originally spun off from Pfizer in 2013 as the world's largest pure-play animal health company, Zoetis (NYSE:ZTS) discovers, develops, and sells medicines, vaccines, diagnostic products, and services for pets and livestock animals worldwide. Why Should ZTS Be on Your Watchlist? Constant currency growth averaged 9.1% over the past two years, showing it can expand globally regardless of the macroeconomic environment ZTS is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders Stellar returns on capital showcase management's ability to surface highly profitable business ventures Zoetis is trading at $167.14 per share, or 27.1x forward P/E. Is now the right time to buy? Find out in our full research report, it's free. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
Burlington Earnings: What To Look For From BURL
Off-price retail company Burlington Stores (NYSE:BURL) will be reporting earnings tomorrow morning. Here's what to look for. Burlington beat analysts' revenue expectations by 0.9% last quarter, reporting revenues of $3.28 billion, up 4.8% year on year. It was a slower quarter for the company, with EPS guidance for next quarter missing analysts' expectations significantly and full-year EPS guidance missing analysts' expectations. Is Burlington a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Burlington's revenue to grow 7% year on year to $2.53 billion, slowing from the 10.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.43 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Burlington has missed Wall Street's revenue estimates four times over the last two years. Looking at Burlington's peers in the general merchandise retail segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Ross Stores delivered year-on-year revenue growth of 2.6%, beating analysts' expectations by 0.5%, and TJX reported revenues up 5.1%, topping estimates by 0.7%. Ross Stores traded down 9.8% following the results while TJX was also down 4%. Read our full analysis of Ross Stores's results here and TJX's results here. There has been positive sentiment among investors in the general merchandise retail segment, with share prices up 11.4% on average over the last month. Burlington is up 11% during the same time and is heading into earnings with an average analyst price target of $325.11 (compared to the current share price of $252.74). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
